Eric S. Wang
Sanford Burnham Prebys Medical Discovery Institute(US)Discovery Institute(US)Center for Discovery(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Protein Degradation and Inhibitors, Ubiquitin and proteasome pathways, Immune cells in cancer, Advanced Breast Cancer Therapies
Most-Cited Works
- → CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation(2017)756 cited
- → Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids(2017)559 cited
- → Development of Dual and Selective Degraders of Cyclin‐Dependent Kinases 4 and 6(2019)255 cited
- → Homolog-Selective Degradation as a Strategy to Probe the Function of CDK6 in AML(2018)247 cited
- → CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung Cancer(2019)219 cited
- → Bruton tyrosine kinase degradation as a therapeutic strategy for cancer(2018)166 cited
- →